genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Human cytomegalovirus
Drug Discovery
Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial
News
Chimerix Names New CEO, a Month after Compassionate Use Flap
Insights
Antisense Drugs Finally Turning the Corner
Cancer
Vical Scraps Melanoma Candidate After Phase III Failure
Cancer
Clinigen Buys Cardioxane from Novartis for $33M
Infectious Diseases
Merck & Co. Nabs Human CMV Portfolio for $142M Up Front
Drug Discovery
Viral Load Assay Employed for Phase III CMV Vaccine Trial
Infectious Diseases
FDA Sanctions Roche’s CMV Test
Insights
Drivers and Hurdles for qPCR
Infectious Diseases
Brazil Clears Quest’s Simplexa Dengue Assay on 3M Integrated Cycler
1
2
3
4
Page 2 of 4
Scroll Up